Ron Herings
Overview
Explore the profile of Ron Herings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pajouheshnia R, Gini R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5871.
PMID: 39145406
Purpose: Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency-funded project (EUPAS39322), defined a set of metadata to describe real-world data sources (RWDSs) and...
2.
Gini R, Pajouheshnia R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5884.
PMID: 39145403
No abstract available.
3.
Andriessen C, Blom M, van Hoek B, de Boer A, Denig P, de Wit G, et al.
Trials
. 2024 Jul;
25(1):505.
PMID: 39049109
Background: Older patients with type 2 diabetes mellitus (T2D) have an increased risk of hypoglycaemic episodes when using sulphonylureas or insulin. In the Netherlands, guidelines exist for reducing glucose-lowering medication...
4.
Brobert G, Ruigomez A, Schink T, Voss A, Herings R, Smits E, et al.
BMJ Open
. 2024 Mar;
14(3):e081348.
PMID: 38531587
Objectives: To describe opportunities and challenges experienced from the four pharmacoepidemiological database studies included in the rivaroxaban post authorisation safety study (PASS) programme and propose ways to maximise the value...
5.
Duran C, Riera-Arnau J, Abtahi S, Pajouheshnia R, Hoxhaj V, Gamba M, et al.
Front Pharmacol
. 2023 Sep;
14:1207976.
PMID: 37663263
In March 2018, the European pregnancy prevention programme for oral retinoids was updated as part of risk minimisation measures (RMM), emphasising their contraindication in pregnant women. To measure the impact...
6.
Houben E, de Jong H, Penning-van Beest F, Kuiper J, Holthuis E, Blum M, et al.
Vector Borne Zoonotic Dis
. 2023 Apr;
23(4):230-236.
PMID: 37071403
There is a need for updated incidence rates (IRs) of Lyme borreliosis (LB) in Europe, including the Netherlands. We estimated LB IRs stratified by geographic area, year, age, sex, immunocompromised...
7.
Reilev M, Jensen P, Ranch L, Egeberg A, Furu K, Gembert K, et al.
BMJ Open
. 2023 Feb;
13(2):e066057.
PMID: 36725094
Introduction: Safe and effective pharmacological treatment is of paramount importance for treating severe psoriasis. Brodalumab, a monoclonal antibody against interleukin (IL) 17 receptor A, was granted marketing authorisation in the...
8.
Holthuis E, Smits E, Spentzouris G, Beier D, Enders D, Gini R, et al.
Drugs Real World Outcomes
. 2022 Jul;
9(4):597-607.
PMID: 35790603
Background: A high degree of adherence to direct oral anticoagulants is essential for reducing the risk of ischaemic stroke and systemic embolism in patients with atrial fibrillation, owing to the...
9.
Smits E, Andreotti F, Houben E, Crijns H, Haas S, Spentzouris G, et al.
Drugs Real World Outcomes
. 2022 Jan;
9(2):199-209.
PMID: 34993898
Background: Direct oral anticoagulants are available for patients with atrial fibrillation. Objective: This study compared adherence and persistence of once-daily (QD) vs twice-daily (BID) direct oral anticoagulants in patients with...
10.
Slieker R, van der Heijden A, Siddiqui M, Langendoen-Gort M, Nijpels G, Herings R, et al.
BMJ
. 2021 Sep;
374:n2134.
PMID: 34583929
Objectives: To identify and assess the quality and accuracy of prognostic models for nephropathy and to validate these models in external cohorts of people with type 2 diabetes. Design: Systematic...